Modeling and Simulation Archives

Video

Certara IQ™: Predicting Recommended Phase 2 Doses with Confidence

Learn how Certara IQ predicts recommended Phase 2 doses using advanced QSP modeling workflows that…

CertaraOctober 16, 2025

Video

Certara IQ™: Model-Informed First-In-Human (FIH) Dose Selection

Discover how Certara IQ uses QSP modeling to predict safe and effective First-In-Human doses, accelerating…

CertaraOctober 16, 2025

Video

Inside Certara IQ™: Building the Future of QSP with Josh Apgar & Chris Bouton

Hear from Certara experts on how Certara IQ modernizes QSP modeling with AI, collaboration tools,…

CertaraOctober 16, 2025

Live Events

PKUK 2025 Pre-Conference Workshop: Modeling & Simulation Updates – QSP and PK/PD Software

– Scarman, Coventry, UK

CertaraOctober 14, 2025

Conference

ICAComP 2025

CertaraOctober 8, 2025

Conference

Dutch Medicines Days

CertaraOctober 7, 2025

White Paper

C-QTc and C-QT Analysis: Replacing TQT Studies and Accelerating Cardiovascular Safety Decisions

Replace or waive TQT studies with validated C-QT analysis strategies accepted by FDA, EMA, PMDA.…

CertaraOctober 3, 2025

Case Study

Certara & Dizal Partner to Fast-Track FDA Approval of Sunvozertinib for Lung Cancer

Certara’s support enabled fast-track FDA oncology approval 2025 for Sunvozertinib, a breakthrough NSCLC therapy targeting…

CertaraOctober 2, 2025

Blog

Best Practices in Clinical Pharmacology Gap Analysis

September 19, 2025 Submitting your New Drug Application (NDA) to the FDA is the ultimate…

CertaraSeptember 19, 2025

Announcement

Certara Launches Libra™: AI-Powered Drug-Induced Liver Injury Prediction Tool

RADNOR, Pa. – September 17, 2025 – Certara, Inc. (Nasdaq: CERT), a global leader in…

CertaraSeptember 17, 2025

Modeling and Simulation

Certara IQ™: Predicting Recommended Phase 2 Doses with Confidence

Certara IQ™: Model-Informed First-In-Human (FIH) Dose Selection

Inside Certara IQ™: Building the Future of QSP with Josh Apgar & Chris Bouton

PKUK 2025 Pre-Conference Workshop: Modeling & Simulation Updates – QSP and PK/PD Software

ICAComP 2025

Dutch Medicines Days

C-QTc and C-QT Analysis: Replacing TQT Studies and Accelerating Cardiovascular Safety Decisions

Certara & Dizal Partner to Fast-Track FDA Approval of Sunvozertinib for Lung Cancer

Best Practices in Clinical Pharmacology Gap Analysis

Certara Launches Libra™: AI-Powered Drug-Induced Liver Injury Prediction Tool

Newsletter sign up

Quick links

Solutions

Contact